Trust Collapsing. It’s Time to Rebuild FDA Transparency
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
We outline common circumstances where index funds may be preferable to ETFs, including buy-and-hold strategies and simplicity.
24,914 articlesTrust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
JPMorgan Chase's CEO says the public frustration with wealth concentration is real, and calls for policy and corporat...
Investors are eyeing a renewed push for a classic dividend king as a robust oncology portfolio and resilience in earn...
Ethereum hit a six-week high above $1,900, extending gains after cooler inflation data. Analysts point to a mix of ma...
TSMC is set to release Q2 results on July 16, 2026 as investors weigh a record profit jump and the path forward for A...
Insider trades can offer clues about a company’s near-term path. This article digs into a Mineralys insider banked $5...
Archer Aviation stock just slipped below the $5 mark, prompting a re-evaluation of its long-term potential. This arti...
June data reveal a surprising split: housing starts topped expectations while housing permits near cycle lows, hintin...
As Iran escalates into conflict 2.0 and mortgage rates linger near the sixes, the housing market faces new tests. Thi...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
Palantir faces a pivotal investor update that could move the stock. This guide breaks down the risks, catalysts, and ...
Verizon raises its dividend with a high yield, while Johnson & Johnson offers steadier growth and a long payout histo...